Funding Open access funding provided by Helmholtz Zentrum Mnchen - Deutsches Forschungszentrum fr Gesundheit und Umwelt (GmbH) Ethics declarations Competing interests M.H.T
Glucose control The SURPASS studies enrolled populations that were similar in terms of baseline HbA1c levels, which ranged from 7.9 to 8.5% [2, 3, 59,60,61] and found a statistically significant reduction in HbA1c already at the 5 mg dose, demonstrating a greater efficacy of tirzepatide compared to placebo or active comparator [2, 3, 59,60,61]
And thats when semaglutide drugs began to be used not just for treating diabetes, but for tackling obesity too
GLP-1 receptor activation reduces appetite, slows gastric emptying, promotes insulin secretion from pancreatic beta cells, and creates the characteristic feeling of fullness that GLP-1 agonist users report
Alternative Research Intensities *Independent research variants for specific volumetric study parameters.
GLP-1 agonists are medications approved for the treatment of diabetes and weight loss